Listed

Premier Air Charter Holdings Inc.: Form 10-Q for the period ended Dec 31, 2019

Filed with the SEC on May 28, 2020 and accepted by EDGAR at May 28, 2020, 14:18 ET.

Share

Management's discussion and analysis

As filed, 8,682 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections. We may use words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “foresee,” “estimate” and variations of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted. You should read this report completely and with the understanding that actual future results may be materially different from what we expect. The forward-looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Our Business

Altair International Corp. (“Altair”) is a development stage company that was incorporated in Nevada on December 20, 2012.

The Company is currently engaged in identifying and assessing new business opportunities.

The Company had previously planned to enter into license and distribution agreements for oral thin film nutraceutical products. This plan was abandoned in the 2017 fiscal year as the Company was unable to obtain the working capital required to bring the products to market.

RESULTS OF OPERATIONS

We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional funds through, among other things, the sale of equity or debt securities, although no assurance can be given that such funds will be available.

Working Capital

As of December 31, 2019 As of March 31, 2019
Total Current Assets $2,165 2,281
Total Current Liabilities 53,012 50,737
Working Capital (Deficit) $(50,847) (48,456)

Cash Flows

Nine Months Ended December 31, 2019 Nine Months Ended December 31, 2018
Cash Flows from (used in) Operating Activities $(116) (79,959)
Cash Flow from (used in) Investing Activities — —
Cash Flows from (used in) Financing Activities — 85,000
Net Increase (decrease) in Cash during period $(116) (5,041)

Operating Revenues

During the nine month period ending December 31, 2019, the Company did not record any revenue. During fiscal year ended March 31, 2019, the Company did not generate any revenue.

Operating Expenses and Net Loss

Operating expenses during the three month period ended December 31, 2019 were $345 consisting of general and administrative expenses which includes corporate overhead and financial and contracted services, as compared to $12,169 for the three month period ended December 31, 2018.

Interest expense for the three month period ended December 31, 2019 was $454 as compared to $454 for the three month period ended December 31, 2018.

Net loss for the three month period ended December 31, 2019 was $799, in comparison to net loss of $12,623 for the three months ended December 31, 2018.

Liquidity and Capital Resources

At December 31, 2019, the Company’s current assets were $2,165 and at March 31, 2019 were $2,281. At December 31, 2019, the Company had total liabilities of $53,012, consisting of a $30,000 Promissory Note payable to a related party, $14,165 in loans payable to a third party, accounts payable of $6,120 and $2,727 in interest payable. At December 31, 2019, the Company had a working capital deficit of $50,847.

At December 31, 2018, the Company’s current assets were $8,683 and at March 31, 2018 were $751. At December 31, 2018, the Company had total liabilities of $45,092, consisting of interest payable of $927, a $30,000 Promissory Note payable to a related party and $14,165 in loans payable to a third party. At December 31, 2018, the Company had a working capital deficit of $36,409.

Cash flow from/used in Operating Activities

We have not generated positive cash flows from operating activities. During the nine month period ended December 31, 2019, the Company used $116 of cash for operating activities. For the nine month period ended December 31, 2018 the Company used $79,959 of cash for operating activities.

Cash flow from Financing Activities

We have financed our operations primarily from either advancements or the issuance of equity and debt instruments. During the nine month period ended December 31, 2019, the Company received $Nil from financing activities. For the nine month period ended December 31, 2018 the Company received $85,000 of cash net of loan repayments from financing activities

Going Concern

We have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive acquisitions and activities. For these reasons, our auditors stated in their report on our audited financial statements that they have substantial doubt that we will be able to continue as a going concern without further financing. The financial statements have been prepared "assuming that we will continue as a going concern," which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business.

Off-Balance Sheet Arrangements

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

Future Financings

We will continue to rely on equity sales of our common shares or debt financing arrangements in order to continue to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the equity securities or arrange for debt or other financing to fund our operations and other activities.

Critical Accounting Policies

Our financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

We regularly evaluate the accounting policies and estimates that we use to prepare our financial statements. A complete summary of these policies is included in the notes to our financial statements. In general, management's estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from those estimates made by management.

Contractual Obligations

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Recently Issued Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Market risk

As filed, 163 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Controls and procedures

As filed, 2,629 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding required disclosure.

An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures, as required by Exchange Act Rule 13a-15. Based on that evaluation, our management concluded that our disclosure controls and procedures were effective as of December 31, 2019 to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate control over financial reporting (as defined in Rule 13a-15(f) promulgated under the Exchange Act. Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2019. Our management has concluded that, as of December 31, 2019, our internal control over financial reporting is effective.

Changes in Internal Control and Financial Reporting

There has been no change in our internal control over financial reporting identified in connection with our evaluation we conducted of the effectiveness of our internal control over financial reporting as of December 31, 2019, that occurred during our third fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

This quarterly report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to temporary rules of the SEC that permit the Company to provide only management’s report in this quarterly report.

Risk factors

As filed, 153 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Interest expense3 months2019-10-01 to 2019-12-31$454us-gaap:InterestExpense
Interest expense9 months2019-04-01 to 2019-12-31$1.4kus-gaap:InterestExpense
Net income3 months2019-10-01 to 2019-12-31−$799us-gaap:NetIncomeLoss
Net income9 months2019-04-01 to 2019-12-31−$2.4kus-gaap:NetIncomeLoss
Diluted EPS3 months2019-10-01 to 2019-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2019-04-01 to 2019-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2019-04-01 to 2019-12-31−$116us-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-12-31$20us-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-12-31$2.2kus-gaap:AssetsCurrent
Total assetsAt period end2019-12-31$2.2kus-gaap:Assets
Current liabilitiesAt period end2019-12-31$53.0kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-12-31$53.0kus-gaap:Liabilities
Shareholders' equityAt period end2019-12-31−$50.8kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001554795-20-000154. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.